Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant gram-negative bacilli

Author(s):  
Keisuke Kagami ◽  
Nobuhisa Ishiguro ◽  
Takehiro Yamada ◽  
Yusuke Niinuma ◽  
Sumio Iwasaki ◽  
...  
2018 ◽  
Vol 20 (1) ◽  
pp. 24-34 ◽  
Author(s):  
Roman S. Kozlov ◽  
Olga U. Stetsiouk ◽  
Irina V. Andreeva

The rapid spread of multidrug-resistant Gram-negative bacteria in hospital settings all over the world makes a demand for the new options to overcome antimicrobial resistance. Ceftazidime-avibactam is the first approved antibiotic that contains a new beta-lactamase inhibitor with unique properties. This review provides insight into the spectrum of activity, pharmacological characteristics, data on efficacy and safety of ceftazidime-avibactam obtained from the clinical trials and real clinical practice, as well as prospects for further studies and clinical application of this new antimicrobial agent.


2021 ◽  
Author(s):  
Xukai Jiang ◽  
Nitin A. Patil ◽  
Mohammad A. K. Azad ◽  
Hasini Wickremasinghe ◽  
Heidi Yu ◽  
...  

Multidrug-resistant Gram-negative bacteria have been an urgent threat to global public health. Novel antibiotics are desperately needed to combat these 'superbugs'.


Sign in / Sign up

Export Citation Format

Share Document